Transoral CO2 Laser Surgery of Supraglottic Cancer.
- Author:
Jong Chul HONG
1
;
Kang Dae LEE
;
Tae Hyun YU
;
Hwan Ho LEE
;
Joo Yeon KIM
;
Sung Won KIM
;
Young Jin HAN
;
Woo Sung KIM
;
Jae Hoon LEE
Author Information
1. Department of Otolaryngology-Head & Neck Surgery, Kosin University College of Medicine, Gospel Hospital, Busan, Korea. kdlee@ns.kosinmed.or.kr
- Publication Type:Original Article
- Keywords:
Laryngeal cancer;
Laryngectomy;
Laser surgery
- MeSH:
Humans;
Laryngeal Neoplasms;
Laryngectomy;
Laser Therapy;
Lasers, Gas;
Neck;
Postoperative Complications;
Retrospective Studies;
Survival Rate
- From:Korean Journal of Otolaryngology - Head and Neck Surgery
2008;51(11):1030-1035
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND AND OBJECTIVES: Endoscopic supraglottic laryngectomy by CO2 laser for selected T1-T3 supraglottic cancer results in improved postoperative function and decreased morbidity, with comparable survival to open surgery. The aim of this study was to retrospectively evaluate oncologic and functional outcomes after transoral CO2 laser surgery for supraglottic cancers. SUBJECTS AND METHOD: Nineteen patients (Fresh group:13 patients, Radiotherapy failure group:6 patients) who were diagnosed as supraglottic cancer and treated with CO2 laser surgery between December, 1999 and September, 2006 were evaluated. All the patients were followed-up more than 12 months. Eleven patients in the Fresh group underwent neck dissection. RESULTS: Ultimate local control rate was 100% for both Fresh group and RT failure group. Survival rates of 3-year and 5-year for the Fresh group and the RT failure group were 100% and 68.6%, and 75% and 50%, respectively. There were no significant postoperative complications. CONCLUSION: Although our experience with supraglottic cancers treated by transoral CO2 laser surgery is still too limited to confirm the definite oncologic and functional results, transoral CO2 laser surgery seems to be a safe and reasonable tool, and a time and cost-effective alternative to the traditional surgery for selected supraglottic cancers.
